Cultivation Expert in bioreactor scale | Amol University of Special Modern Technologies | Iran
Dr. Seyed Amir Hossein Mohammadzadeh Hosseini Moghri is an accomplished researcher whose work centers on microbial biotechnology, molecular genetics, and the design of vaccines targeting Nosocomial Infections. His academic journey includes advanced studies in microbial biotechnology and cell and molecular biology, leading to significant achievements in immunoinformatics and recombinant protein production. With professional experience at AryoGen Pharmed and academic teaching in genetic engineering, Dr. Mohammadzadeh Hosseini Moghri has demonstrated strong expertise in bioreactor cultivation, cell culture, and protein expression. His research interests encompass Nosocomial Infections, vaccine development, gene cloning, and bioinformatics-based immunogenic analysis. Dr. Mohammadzadeh Hosseini Moghri has received national recognition as a member of the National Elite Foundation and has registered genes of SARS-CoV-2 in NCBI, underscoring his contributions to infectious disease research. His publications highlight innovative approaches in combating Nosocomial Infections through multi-epitope vaccine design and bioinformatics analysis. He has been honored as an outstanding biotechnology student and recognized for improving recombinant drug expression. His research skills include advanced laboratory techniques, immunoinformatics modeling, and molecular diagnostics, which have been applied effectively in the study of Nosocomial Infections and related microbial mechanisms. His scientific commitment and multidisciplinary approach reflect his dedication to tackling the challenges posed by Nosocomial Infections in healthcare environments. His expertise continues to enhance understanding of Nosocomial Infections and innovative therapeutic interventions. Google Scholar profile of 52 Citations, 6 h-index, 2 i10-index.
Profile: Google Scholar
Featured Publications
1. Farrokhi, M., Ghalamkarpour, N., Nouri, S., Babaei, M., Rajabloo, Y., Sattari, M., & others. (2025). Innovative vaccination: A new era in cancer prevention. Kindle, 5(1), 1–194.
2. Javadi, K., Emadzadeh, M. R., Moghri, S. A. H. M. H., Halaji, M., Parsian, H., & others. (2025). Anti-biofilm and antibacterial effect of bacteriocin derived from Lactobacillus plantarum on the multidrug-resistant Acinetobacter baumannii. Protein Expression and Purification, 226, 106610.
3. Mohammadzadeh Hosseini Moghri, S. A. H., Ranjbar, M., Hassannia, H., & others. (2023). In silico analysis of the conserved surface-exposed epitopes to design novel multiepitope peptide vaccine for all variants of the SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 41(16), 7603–7615.
4. Mohammadzadeh Hosseini Moghri, S. A. H., Ranjbar, M., Hassannia, H., & Khakdan, F. (2021). Designing a novel multi-epitope vaccine against SARS-CoV-2: Implication for viral binds and fusion inhibition through inducing neutralizing antibodies. BioRxiv.
5. Mohammadzadeh Hosseini Moghri, S. A. H., Mahmoodi Chalbatani, G., & others. (2023). CD171 multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastoma. Journal of Biomolecular Structure and Dynamics, 41(3), 1028–1040.